Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy

President Joe Biden's shaky debate performance this week is stirring doubts among Democrats about his viability for reelection. As doubts about the president's electability circulate, questions around

BenzingaJun 29 10:53 ET

Aurora Cannabis Shoots For $512M Market: Marijuana Stock Analyst Initiates Coverage With Neutral

Aurora Cannabis (NASDAQ:ACB), a key player in the global medical marijuana market, stands at a strategic crossroads. Pablo Zuanic, a seasoned marijuana stock analyst from Zuanic & Associates, has init

BenzingaJun 28 15:13 ET

Express News | Shares of Cannabis Stocks Are Trading Lower. The Sector May Be Moving as Investors Assess Thursday's Presidential Debate and 2024 Election Outlook

BenzingaJun 28 12:46 ET

Zuanic & Associates Initiates Coverage On Aurora Cannabis With Neutral Rating

Zuanic & Associates analyst Pablo Zuanic initiates coverage on Aurora Cannabis (NASDAQ:ACB) with a Neutral rating.

BenzingaJun 27 06:51 ET

Aurora Cannabis Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/27/2024 — Zuanic & Associates Initiates Coverage On → Neutral 06/16/2023 -78.63% CIBC $1.75 → $1 Maint

BenzingaJun 27 06:50 ET

Canadian Vs. U.S. Cannabis Companies: Who Is Winning The Market Race To Weed Profits?

The financial landscapes of Canadian and U.S. cannabis operators showcase distinct paths in the quest for profitability, driven by varying market dynamics and regulatory environments. According to rec

BenzingaJun 25 19:01 ET